Morgan Stanley’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.62M Sell
318,542
-229,242
-42% -$1.07M ﹤0.01% 4973
2026
Q1
$1.94M Buy
547,784
+118,756
+28% +$487K ﹤0.01% 4783
2025
Q4
$2.03M Sell
429,028
-341,697
-44% -$1.52M ﹤0.01% 4798
2025
Q3
$3.69M Buy
770,725
+586,593
+319% +$2.31M ﹤0.01% 4384
2025
Q2
$444K Buy
184,132
+5,279
+3% +$13K ﹤0.01% 5523
2025
Q1
$467K Sell
178,853
-13,428
-7% -$43.3K ﹤0.01% 5358
2024
Q4
$733K Sell
192,281
-156,094
-45% -$842K ﹤0.01% 5243
2024
Q3
$2.5M Sell
348,375
-307,019
-47% -$2.18M ﹤0.01% 4491
2024
Q2
$4.8M Buy
655,394
+44,626
+7% +$389K ﹤0.01% 3906
2024
Q1
$6.11M Buy
610,768
+296,280
+94% +$2.59M ﹤0.01% 3758
2023
Q4
$2.2M Sell
314,488
-524,985
-63% -$3.49M ﹤0.01% 4451
2023
Q3
$6.67M Buy
839,473
+465,046
+124% +$2.93M ﹤0.01% 3494
2023
Q2
$2.07M Sell
374,427
-26,850
-7% -$147K ﹤0.01% 4400
2023
Q1
$2.28M Sell
401,277
-648,018
-62% -$4.29M ﹤0.01% 4377
2022
Q4
$7.33M Sell
1,049,295
-1,326,842
-56% -$13.6M ﹤0.01% 3385
2022
Q3
$21.2M Sell
2,376,137
-355,272
-13% -$4.1M ﹤0.01% 2131
2022
Q2
$28.3M Buy
2,731,409
+1,138,280
+71% +$16.9M ﹤0.01% 1911
2022
Q1
$33.2M Buy
1,593,129
+481,769
+43% +$10.5M ﹤0.01% 1615
2021
Q4
$28.4M Sell
1,111,360
-455
-0% -$12.6K ﹤0.01% 1796
2021
Q3
$35.1M Buy
1,111,815
+413,559
+59% +$14.3M ﹤0.01% 1552
2021
Q2
$27.9M Buy
698,256
+124,522
+22% +$5.06M ﹤0.01% 1805
2021
Q1
$24.3M Buy
573,734
+440,264
+330% +$20.3M ﹤0.01% 1734
2020
Q4
$4.87M Buy
133,470
+132,370
+12,034% +$3.95M ﹤0.01% 3282
2020
Q3
$24K Buy
+1,100
New +$24.6K ﹤0.01% 5995

Other funds holding MSOS

Morgan Stanley's MSOS Position: Q2 2026 in Review

Morgan Stanley reduced its AdvisorShares Pure US Cannabis ETF (MSOS) stake by 42% in Q2 2026, selling an estimated $1.07M and leaving 318,542 shares worth $1.62M. The position accounts for ﹤0.01% of the portfolio, ranked #4973.

Morgan Stanley first reported a position in MSOS in Q3 2020 and has held it in 24 quarters since. The position peaked at $35.1M in Q3 2021. 169 funds tracked by Wall St. Rank hold MSOS as of Q2 2026.

  • Morgan Stanley held 318,542 shares of AdvisorShares Pure US Cannabis ETF worth $1.62M as of Q2 2026.
  • Morgan Stanley sold 229,242 AdvisorShares Pure US Cannabis ETF shares in Q2 2026, an estimated $1.07M.
  • AdvisorShares Pure US Cannabis ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #4973 holding.
  • Morgan Stanley first reported a position in AdvisorShares Pure US Cannabis ETF in Q3 2020 and has held it in 24 quarters since.
  • Morgan Stanley's AdvisorShares Pure US Cannabis ETF position peaked at $35.1M in Q3 2021.
  • 169 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.